no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health
|
McConeghy, Kevin W. |
|
2016 |
34 |
30 |
p. 3463-3468 6 p. |
article |
2 |
An optimized, highly efficient, self-assembled, subvirus-like particle of infectious bursal disease virus (IBDV)
|
Wang, Miao |
|
2016 |
34 |
30 |
p. 3508-3514 7 p. |
article |
3 |
Detection and characterization of viruses as field and vaccine strains in feedlot cattle with bovine respiratory disease
|
Fulton, R.W. |
|
2016 |
34 |
30 |
p. 3478-3492 15 p. |
article |
4 |
Differential regulation of polysaccharide-specific antibody responses to isolated polysaccharides, conjugate vaccines, and intact Gram-positive versus Gram-negative extracellular bacteria
|
Snapper, Clifford M. |
|
2016 |
34 |
30 |
p. 3542-3548 7 p. |
article |
5 |
DNA vaccination based on pyolysin co-immunized with IL-1β enhances host antibacterial immunity against Trueperella pyogenes infection
|
Huang, Ting |
|
2016 |
34 |
30 |
p. 3469-3477 9 p. |
article |
6 |
Editorial Board/Aims and Scope
|
|
|
2016 |
34 |
30 |
p. IFC- 1 p. |
article |
7 |
Emergency deployment of genetically engineered veterinary vaccines in Europe
|
Ramezanpour, Bahar |
|
2016 |
34 |
30 |
p. 3435-3440 6 p. |
article |
8 |
Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates
|
McBurney, Sean P. |
|
2016 |
34 |
30 |
p. 3500-3507 8 p. |
article |
9 |
Hendra virus and Nipah virus animal vaccines
|
Broder, Christopher C. |
|
2016 |
34 |
30 |
p. 3525-3534 10 p. |
article |
10 |
Human anthelminthic vaccines: Rationale and challenges
|
Hotez, Peter J. |
|
2016 |
34 |
30 |
p. 3549-3555 7 p. |
article |
11 |
Human papillomavirus vaccine series completion: Qualitative information from providers within an integrated healthcare organization
|
Hudson, Sharon M. |
|
2016 |
34 |
30 |
p. 3515-3521 7 p. |
article |
12 |
Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older
|
Frenck Jr., Robert W. |
|
2016 |
34 |
30 |
p. 3454-3462 9 p. |
article |
13 |
Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system
|
Zhang, Qicheng |
|
2016 |
34 |
30 |
p. 3447-3453 7 p. |
article |
14 |
Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis
|
Stegmiller, Nataly Pescinalli |
|
2016 |
34 |
30 |
p. 3493-3499 7 p. |
article |
15 |
Introduction to issue of highlighted research presented at the 2015 National Foundation for Infectious Diseases Annual Conference on Vaccine Research
|
Orenstein, Walter A. |
|
2016 |
34 |
30 |
p. 3522-3524 3 p. |
article |
16 |
Reduced serologic sensitivity to influenza A virus illness among inactivated influenza vaccinees
|
Thompson, Mark G. |
|
2016 |
34 |
30 |
p. 3443-3446 4 p. |
article |
17 |
Vaccines against respiratory syncytial virus: The time has finally come
|
Graham, Barney S. |
|
2016 |
34 |
30 |
p. 3535-3541 7 p. |
article |
18 |
Zika vaccine misconceptions: A social media analysis
|
Dredze, Mark |
|
2016 |
34 |
30 |
p. 3441-3442 2 p. |
article |